Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-03-04
1994-12-06
Hook, Gregory
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514266, 514844, A61K 3152
Patent
active
053710894
ABSTRACT:
Compositions and methods are provided for countering the adverse effects of aging on cells in culture and in vivo in which cells are contacted with the compositions that ameliorate the adverse effects of aging on mammalian cells by slowing or reversing the changes that normally accompanying aging of such cells but do not significantly increase the growth rate or total proliferative capacity of such cells. The compositions contain one or more 6-(substituted amino)purine cytokinins and preferably do not contain ingredients that promote cell division or that induce or potentiate the ability of the 6-(substituted amino) purine cytokinins to promote cell division.
Among the preferred applications of the compositions and methods provided herein are the preservation of or restoration of the health of mammalian cells in culture and, by application of the compositions to human skin, the health and youthful appearance of the skin.
REFERENCES:
patent: 3126318 (1964-03-01), Legator
patent: 4581056 (1986-04-01), Nooden et al.
patent: 4610978 (1986-09-01), Dikstein et al.
patent: 4853386 (1989-08-01), Friebe et al.
patent: 5021422 (1991-06-01), Bolund et al.
patent: 5151425 (1992-09-01), Clark
Bindra "Anti-Aging Drugs" in Burger's Medicinal Chemistry, Part III, pp. 1-9 1981.
Orr et al., "The effects of kinetin upon epithelium and fibroblasts in tissue culture," Cancer, 10:617-624 (1957).
Johnson et al., "N.sup.6 -substituted adenines induce cell elongation irrespective of the intracellular cyclic AMP levels," Exper. Cell Res., 85:47-56 (1974).
Hecht et al., "Competitive inhibition of beef heart cyclic AMP phosphodiesterase by cytokinins and related compounds," Proc. Natl. Acad. Sci. USA, 71:4670-4674 (1974).
Mookerjee et al., "Effects of plant cytokinins on human lumphocyte transformation," J. Reticuloendothel. Soc., 25:299-314 (1979).
Sacchi et al., "Changes in form of Elongation Factor 1 during germination of wheat seeds," Eur. J. Biochem., 139:1-4 (1984).
Spirin et al., "Informosomes and polybribosome-associated proteins in eukaryotes," Trends in Biochem. Sci., 10:162-164 (1985).
Vesely et al., "Plant growth-promoting hormones activate mammalian guanylate cyclase activity," Endocrinology, 116:1887-1892 (1985).
Gordon et al., "6-substituted purines: A novel class of inhibitors of endogenous protein degradation in isolated rat hepatocytes," Arch. Biochem. Biophys., 217:282-294 (1982).
The Merck Index: An Encyclopedia of Chemicals and Drugs, 9th Ed., Merck & Co., Inc., Rahway, N.J., M. Windholz, Ed.; p. 696 (1976).
Weiss et al., "Topical tretinoin improves photoaged skin: A double-blind vehicle-controlled study," JAMA, 259(4):527-532 (1988).
Kligman et al., "The contributions of UVA and UVB to connective tissue damage in hairless mice," J. Investigative Dermatology, 84:272-276 (1985).
Bissett et al., "An animal model of solar-aged skin: Histological, physical, and visible changes in UV-irradiated hairless mouse skin," Photochem. and Photobiol., 46(3):367-378 (1987).
Kligman et al., "Collagen metabolism in ultraviolet irradiated hairless mouse skin and its correlation to histochemical observations," J. Investigative Dermatology, 23(2):210-214 (Aug. 1989).
Schwartz, E., "Connective tissue alternations in the skin of ultraviolet irradiated hairless mice," J. Investigative Deermatology, 91(2):158-161 (1988).
Warren et al., "Age, sunlight, and facial skin: A histologic and quantitative study," J. Amer. Acad. of Dermatology, 25:751-760 (1991).
Bissett et al., "Wavelength dependence of histological, physical, and visible changes in chronically UV-irradiated hairless mouse skin," Photochem. and Photobiol., 50(6):763-769 (1989).
Schwartz et al., "Topical all-trans retinoic acid stimulates collagen synthesis in vivo," J. of Investigative Dermatology, 96(6):975-978 (1991).
Katsaros et al., "Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth," FEBS Letters, 223(1):97-102 (1987).
Wainfan et al., "Inhibition of transfer ribonucleic acid methylating enzymes by cytotoxic analogs of adenosine," Biochem. Pharmacology, 22:493-500 (1973).
Kligman et al., "Long-term histologic follow-up of phenol face peels," Plastic and Reconstructive Surgery, 75(5):652-659 (1985).
Stegman, S., "A comparative histologic study of the effects of three peeling agents and dermabrasion on normal and sundamaged skin," Aesthetic Plastic Surgery, 6:123-135 (1982).
Braverman et al., "Studies in cutaneous aging: I. The elastic fiber network," J. of Investigative Dermatology, 78:434-443 (1982).
Bryce et al., "Retinoic acids promote the repair of the dermal damage and the effacement of wrinkles in the UVB-irradiated hairless mouse," J. of Investigative Dermatology, 91(2):175-180 (1988).
Ethier et al., "Aging increases adenosine and inosine release by human fibroblast cultures," Mechanisms of Ageing and Development, 50:159-168 (1989).
Bissett et al., "Photoprotective effect of topical anti-inflammatory agents against ultraviolet radiation-induced chronic skin damage in the hairless mouse," Photodermatol. Photoimmunol. Photomed., 7:153-158 (1990).
Hook Gregory
Senetek PLC
LandOfFree
Method and composition for ameliorating the adverse effects of a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for ameliorating the adverse effects of a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for ameliorating the adverse effects of a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-214665